4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001012975-18-000201
10% owner acquired 337,452 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novartis Bioventures Ltd 10% owner | 2018-02-13 | Other acquisition | +269,527 | 2,804,088 | I: show line 1 in the form | ||
| Novartis Bioventures Ltd 10% owner | 2018-02-15 | Other acquisition | +67,925 | 2,872,013 | I: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novartis Bioventures Ltd 10% owner | 2018-02-13 | Other disposition · Series B Convertible Preferred Stock | −344.94 | 1,724.69 | I: show line 3 in the form |
Loading xslF345X03/edgar.xml…